Literature DB >> 8173064

The calculation of breast cancer risk for women with a first degree family history of ovarian cancer.

E B Claus1, N Risch, W D Thompson.   

Abstract

Recent linkage analyses demonstrate the strength of the genetic association between breast and ovarian cancer in some families. These findings highlight the importance of considering a woman's family history of ovarian cancer in the calculation of her risk of breast cancer. In this study, data on breast and ovarian cancer from the Cancer and Steroid Hormone Study, a large, population-based, case-control study conducted by the Centers for Disease Control, are used to calculate age-specific and cumulative risks of developing breast cancer for a woman with a first degree family history of ovarian cancer. These risks are calculated using maximum likelihood estimates from an autosomal dominant genetic model fit previously to the observed age-specific recurrence data of breast cancer among first degree relatives of the breast cancer cases and controls in these data as well as from genotype-specific estimates of lifetime ovarian cancer risk derived from this model. Under this model, the lifetime risk of developing breast cancer for a woman with one or two first degree relatives affected with ovarian cancer is estimated to be approximately 13% and 31%, respectively. A woman with one first degree relative affected with ovarian cancer and one first degree relative affected with breast cancer has an estimated risk of 40 percent of developing breast cancer by age 79 years if the relative with breast cancer was diagnosed in her thirties. This risk decreases with increasing age of onset of the relative affected with breast cancer.

Entities:  

Mesh:

Year:  1993        PMID: 8173064     DOI: 10.1007/bf00666424

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  25 in total

1.  Segregation and linkage analysis of nine Utah breast cancer pedigrees.

Authors:  D T Bishop; L Cannon-Albright; T McLellan; E J Gardner; M H Skolnick
Journal:  Genet Epidemiol       Date:  1988       Impact factor: 2.135

2.  Carcinoma of the breast and ovary in three families.

Authors:  H T Lynch; A J Krush
Journal:  Surg Gynecol Obstet       Date:  1971-10

3.  Familial breast-ovarian cancer locus on chromosome 17q12-q23.

Authors:  S A Narod; J Feunteun; H T Lynch; P Watson; T Conway; J Lynch; G M Lenoir
Journal:  Lancet       Date:  1991-07-13       Impact factor: 79.321

4.  Genetic epidemiology of breast cancer and associated cancers in high-risk families. I. Segregation analysis.

Authors:  R C Go; M C King; J Bailey-Wilson; R C Elston; H T Lynch
Journal:  J Natl Cancer Inst       Date:  1983-09       Impact factor: 13.506

5.  Family history of gynaecological cancers: relationships to the incidence of breast cancer prior to age 55.

Authors:  W D Thompson; J M Schildkraut
Journal:  Int J Epidemiol       Date:  1991-09       Impact factor: 7.196

6.  Genetic counseling for families with inherited susceptibility to breast and ovarian cancer.

Authors:  B B Biesecker; M Boehnke; K Calzone; D S Markel; J E Garber; F S Collins; B L Weber
Journal:  JAMA       Date:  1993-04-21       Impact factor: 56.272

7.  Practical guide for estimating risk for familial breast cancer.

Authors:  R Ottman; M C Pike; M C King; B E Henderson
Journal:  Lancet       Date:  1983-09-03       Impact factor: 79.321

8.  Evaluating genetic association among ovarian, breast, and endometrial cancer: evidence for a breast/ovarian cancer relationship.

Authors:  J M Schildkraut; N Risch; W D Thompson
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

9.  Relationship of epithelial ovarian cancer to other malignancies within families.

Authors:  J M Schildkraut; W D Thompson
Journal:  Genet Epidemiol       Date:  1988       Impact factor: 2.135

10.  The evaluation of the data collection process for a multicenter, population-based, case-control design.

Authors:  P A Wingo; H W Ory; P M Layde; N C Lee
Journal:  Am J Epidemiol       Date:  1988-07       Impact factor: 4.897

View more
  47 in total

Review 1.  Clinical and epidemiological issues in mammographic density.

Authors:  Valentina Assi; Jane Warwick; Jack Cuzick; Stephen W Duffy
Journal:  Nat Rev Clin Oncol       Date:  2011-12-06       Impact factor: 66.675

2.  Age at diagnosis and multiple primary cancers of the breast and ovary.

Authors:  P J Suris-Swartz; J M Schildkraut; M F Vine; I Hertz-Picciotto
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Performance of Breast Cancer Risk-Assessment Models in a Large Mammography Cohort.

Authors:  Anne Marie McCarthy; Zoe Guan; Michaela Welch; Molly E Griffin; Dorothy A Sippo; Zhengyi Deng; Suzanne B Coopey; Ahmet Acar; Alan Semine; Giovanni Parmigiani; Danielle Braun; Kevin S Hughes
Journal:  J Natl Cancer Inst       Date:  2020-05-01       Impact factor: 13.506

4.  Breast Cancer Risk - Genes, Environment and Clinics.

Authors:  P A Fasching; A B Ekici; B R Adamietz; D L Wachter; A Hein; C M Bayer; L Häberle; C R Loehberg; S M Jud; K Heusinger; M Rübner; C Rauh; M R Bani; M P Lux; R Schulz-Wendtland; A Hartmann; M W Beckmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2011-12       Impact factor: 2.915

5.  Prospective comparison of family medical history with personal genome screening for risk assessment of common cancers.

Authors:  Brandie Heald; Emily Edelman; Charis Eng
Journal:  Eur J Hum Genet       Date:  2012-01-04       Impact factor: 4.246

6.  Six low-penetrance SNPs for the estimation of breast cancer heritability: A family-based study in Caucasian Italian patients.

Authors:  Simona De Summa; Francesca Graziano; Brunella Pilato; Rosamaria Pinto; Katia Danza; Rosanna Lacalamita; Simona Serratì; Domenico Sambiasi; Mario Grassi; Stefania Tommasi
Journal:  Oncol Lett       Date:  2017-08-04       Impact factor: 2.967

7.  Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis.

Authors:  P A Fasching; A B Ekici; D L Wachter; A Hein; C M Bayer; L Häberle; C R Loehberg; M Schneider; S M Jud; K Heusinger; M Rübner; C Rauh; M R Bani; M P Lux; R Schulz-Wendtland; A Hartmann; M W Beckmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-12       Impact factor: 2.915

Review 8.  Clinical management of women at increased risk for breast cancer.

Authors:  V G Vogel; A Yeomans; E Higginbotham
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

Review 9.  Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk.

Authors:  Steven R Cummings; Jeffrey A Tice; Scott Bauer; Warren S Browner; Jack Cuzick; Elad Ziv; Victor Vogel; John Shepherd; Celine Vachon; Rebecca Smith-Bindman; Karla Kerlikowske
Journal:  J Natl Cancer Inst       Date:  2009-03-10       Impact factor: 13.506

10.  Cancer risk assessment for the primary care physician.

Authors:  Larissa A Korde; Shahinaz M Gadalla
Journal:  Prim Care       Date:  2009-09       Impact factor: 2.907

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.